http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bba4c1c0bd07a6ff394be2c38116daa9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cañamero |
| name | Marta Cañamero |
| given-name | Marta |
| organization-name | Protein Technology Unit and Comparative Pathology Unit, Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain Histopathology Unit Biotechnology Program Spanish National Cancer Research Centre (CNIO) Madrid Spain Histopathology Unit, Centro Nacional de Investigaciones Oncológicas, 28029 Madrid, Spain; and Centro Nacional de Investigaciones Oncológicas, E28029 Madrid, Spain Biotechnology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), E-28029 Madrid, Spain Roche Diagnostics GmbH Penzberg Germany Histopathology Unit, Spanish National Cancer Research Center, Madrid, Spain Histopathology Unit, and Authors' Affiliations: 1Cell Division and Cancer Group; 2Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; and 3Department of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina Authors' Affiliations: 1Cell Division and Cancer Group, Spanish National Cancer Research Center (CNIO); 2Comparative Pathology Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; and 3Department of Microtubules and Cell Division, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid 28029, Spain; Comparative Pathology Unit, Biotechnology Programme, CNIO, Madrid, Spain Spanish National Cancer Center (CNIO) Madrid Spain Comparative Pathology Unit, Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO); Madrid Spain Comparative Pathology Unit, Spanish National Cancer Research Centre, Madrid, Spain Roche Pharmaceutical Research and Early Development Penzberg Germany Biotechnology Programs; Centro Nacional de Investigaciones Oncológicas (CNIO); Madrid Spain Authors' Affiliations: 1Cell Division and Cancer Group, 2Confocal Microscopy and Cytometry Unit, and 3Comparative Pathology Unit, Spanish Nacional Cancer Research Center (CNIO), and 4Hereditary Endocrine Cancer Group, CNIO and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain Comparative Pathology Unit, CNIO, 28029 Madrid, Spain Oncology Medical and Government Affairs Roche Diagnostics EMEA-LATAM Region, Rotkreuz, Switzerland; Comparative Pathology Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO); Madrid Spain Histopathology Unit Spanish National Cancer Research Center (CNIO) Madrid Spain; Pathology and Tissue Analysis Pharma Research and Early Development Roche Innovation Centre Munich Germany Biotechnology Programs, Centro Nacional de Investigaciones Oncológicas, E-28029 Madrid, Spain; |
Incoming Links
Total number of triples: 99.